Research in Maine
- 1 of 3
- next ›
Biopharmaceutical research companies are conducting or have conducted more than 550 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).
Of the more than 550 clinical trials, more than 300 target the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.